Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice
Tapani Ruutu(Helsinki University Hospital), Olle Ringdén(Karolinska Institutet), Jakob Passweg(University Hospital of Basel), Gèrard Socié(Hôpital Saint-Louis), Hildegard Greinix(Medical University of Graz), J. Alejandro Madrigal(Royal Free London NHS Foundation Trust), Mohamad Mohty(Sorbonne Université), Jorge Sierra(Universitat Autònoma de Barcelona), Laurent Garderet(Inserm), Boris V. Afanasyev(First Pavlov State Medical University of St. Petersburg), Ernst Holler(University Hospital Regensburg), Jürgen Finke(University Medical Center Freiburg), Dietger Niederwieser(Leipzig University of Applied Sciences), Ánita Lawitschka(St Anna Children's Hospital), Francesco Dazzi(King's College London), Aloïs Gratwohl, Jane F. Apperley(Hammersmith Hospital), Rafael F. Duarte(Institut Català d'Oncologia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Peter Dreger(Heidelberg University), W Wiktor-Jędrzejczak(Medical University of Warsaw), Andrea Bacigalupo(Università Cattolica del Sacro Cuore), T. de Witte(Radboud University Nijmegen), Nicolaus Kröger(Universität Hamburg), A. Nagler
Cited by 310
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k